Pregled bibliografske jedinice broj: 516207
VLA-4 retargeted adenovirus type 5 as vector for acute myeloid leukemia
VLA-4 retargeted adenovirus type 5 as vector for acute myeloid leukemia // Targeting and Imaging of tumor microenvironment. Book of Abstracts.
Ile Berder, Francuska, 2009. (predavanje, nije recenziran, sažetak, znanstveni)
CROSBI ID: 516207 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
VLA-4 retargeted adenovirus type 5 as vector for acute myeloid leukemia
Autori
Majhen, Dragomira ; Jelušić, Tihana ; Gabrilovac, Jelka ; Ambriović-Ristov, Andreja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Targeting and Imaging of tumor microenvironment. Book of Abstracts.
/ - , 2009
Skup
Targeting and Imaging of tumor microenvironment
Mjesto i datum
Ile Berder, Francuska, 23.09.2009. - 26.09.2009
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Nije recenziran
Ključne riječi
adenovirus; VLA-4; retargeting
Sažetak
Acute myeloid leukemia (AML) is a cancer of the myeloid line of white blood cells, characterized by the rapid proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age. The basic therapeutic approach to patients with AML aged 18-60 years has changed little over the last 3 decades and classically involves chemotherapy treatment which is very invasive and elderly patient poorly tolerate its toxicity. Since less than 40% of AML patients under age of 60 can be cured, and in older adults, accounting for the majority of AML patients, long-term disease-free survival rate is rare with limited available treatment options, there is urgent need for the development of novel targeted therapies for AML. Gene therapy, with emphasis on receptor targeted gene delivery, might be a future option in treating AML.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Projekti:
098-0982913-2850 - Povećanje transdukcije adenovirusnih vektora i otpornost stanica na citostatike (Ambriović Ristov, Andreja, MZOS ) ( CroRIS)
098-0982464-2520 - Uloga membranskih peptidaza na tumorskim i normalnim stanicama (Gabrilovac, Jelka, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Jelka Gabrilovac
(autor)
Dragomira Majhen
(autor)
Andreja Ambriović Ristov
(autor)
Tihana De Zan
(autor)